Advertisement
Trulieve Cannabis Corp.

Trulieve Cannabis Corp. (TRLV) Stock Overview

Explore Trulieve Cannabis Corp.’s financial performance, market position, analyst ratings, and future outlook.

TRLVNYSE
HealthcareMedical - Pharmaceuticals
$8.99
$0.47(5.52%)
U.S. Market opens in 54h 50m
Advertisement

Trulieve Cannabis Corp. (TRLV)

Meyka AI Score

Z

Key Financials

Market Cap1.5B
P/E Ratio-21.31
EPS (TTM)$0.01
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

TRLV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Trulieve Cannabis Corp. (TRLV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 33.92, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -21.31 and a market capitalization of 1.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
5.62%
5-Day Change
-9.65%
1-Month Change
8.42%
3-Month Change
55.16%
6-Month Change
14.06%
Year-to-Date (YTD) Change
3.56%
1-Year Change
147.91%
3-Year Change
127.25%
5-Year Change
-76.86%
All-Time (Max) Change
-14.38%

Contact Information

850 298 8866
3494 Martin Hurst Road, Tallahassee, FL, 32351

Company Facts

50,000 Employees
IPO DateSep 25, 2018
CountryUS
Actively Trading

Frequently Asked Questions